[1] the healthcare system in which the study is done -private (with billing for drugs used) vs. government funded; primary care vs. secondary care.
[2] severity of gout and age of patients (older typically will have higher adherence). This ought to be discussed.
I would like to draw the authors' attention to a study where we reported an adherence rate of 85% (Rheumatology (Oxford). 2017 Apr 1;56(4):529-533. doi: 10.1093/rheumatology/kew395.). This and the related study by Rees et al. should be discussed as there are excellent adherence rates after nurse led treatment of gout.
A discussion on how to improve adherence will enhance the quality of the work.
VERSION 1 -AUTHOR RESPONSE
For Reviewer 1 Comment 1. In the introduction,page 6, 21, in non-medication therapy, the authors forget to mention the adherence to diet recommendations.
Response: Thanks for your suggestions very much! On pages 6 and 21, we have added the part of the adherence to diet recommendations in non-medication therapy.
Comment 2. page 6. 21: were excluded articles "that used the term "adherence" but actualy measured persitence or retention rate or treatment gaps". This should be justified.
Response: Thanks very much for your great suggestions! "Articles on persistence, discontinuation, switching, treatment gap, or retention rate" was one of the exclusion criteria. When browsing articles, we found that some articles used the term "adherence" but actualy measured persitence or retention rate or treatment gaps, so these articles were also excluded.
After the pain disappears, the patient ofthen thinks the gout is cured and stops taking drugs. So it is possible that non-adherence in gout is as bad as in silent disease, even worse. We have added a lot of discussion based on the comments you, the other reviewer, editor and the associate editor have given, so we will not discuss this part of the article. Nevertheless, I would like to thank you for your great suggestions.
For Reviewer 2 Comment 1. The authors have not searched Embase and Cochrane databases. The reasons for this should be discussed. They note significant difference in adherence in claims database, especially from the USA, and also from UK. The reasons for this need discussing. Could it be that interview studies or postal surveys are prompting patients to self-report higher adherence.
Response: Thank you for the helpful suggestions! We have discussed the reasons for not searching Embase and Cochrane databases, as well as the reasons for significant difference in adherence in claims database, especially from the USA, and also from UK the revised proof.
Comment 2. Adherence also depends on [1] the healthcare system in which the study is done -private (with billing for drugs used) vs. government funded; primary care vs. secondary care.
